Table 3 Baseline characteristics of the included studies
Study ID | Sample n (%) | Age, year, mean (SD) | Sex, female n (%) | BMI, kg/m2, mean (SD) | |||||
|---|---|---|---|---|---|---|---|---|---|
Antibiotic | Placebo | Total | Antibiotic | Placebo | Antibiotic | Placebo | Antibiotic | Placebo | |
Braak et al. 2022 | 226 | 231 | 457 | 58.0 (13.9) | 57.5 (14.6) | 119 (52.7) | 114 (49.4) | 28.8 (5.2) | 28.7 (5.1) |
Jaafar et al. 2020a | 42 | 48 | 90 | 48.5 (24) | 49 (25) | 24(57.1) | 25(52.1) | 27 (7) | 28 (6) |
Park et al. 2023 | 125 (50.6) | 122 (49.4) | 247 | 51.6 (15.51) | 52.4(13.71) | 62 (49.6) | 75 (61.5) | 25 (3.47) | 24.5 (3.79) |
Kim et al. 2017 | 93 | 95 | 188 | 52.1 (15.3) | 52(15) | 44(47.31) | 49(51.58) | 24.8 (3.4) | 25 (4) |
Loozen et al. 2017a | 77 | 73 | 150 | 52 (66) | 54 (58) | 45 (58.4) | 35 (48) | - | - |
Regimbeau et al. 2014a | 207 | 207 | 414 | 55 (75) | 56 (74) | 107(51.7) | 103(49.8) | - | - |
Santibañes et al. 2018 | 96 | 105 | 201 | 49.9 (14.7) | 49.9 (14.3) | 44(45.8) | 57(54.3) | 28.6 (5.2) | 28.2 (4.3) |